vs
金罗斯黄金(GOLD)与PUMA BIOTECHNOLOGY, INC.(PBYI)财务数据对比。点击上方公司名可切换其他公司
金罗斯黄金的季度营收约是PUMA BIOTECHNOLOGY, INC.的2.0倍($148.1M vs $75.5M),PUMA BIOTECHNOLOGY, INC.同比增速更快(27.7% vs -94.6%),PUMA BIOTECHNOLOGY, INC.自由现金流更多($14.4M vs $-46.6M),过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高(31.3% vs -76.2%)
金罗斯黄金公司是一家总部位于加拿大多伦多的金银开采企业,成立于1993年。目前公司共运营六座在产金矿,矿区分布在巴西、毛里塔尼亚与美国境内,在2019年InvestingNews评选的全球十大黄金开采企业中位列第五。
彪马生物技术是一家公开上市的生物制药企业,总部位于美国加利福尼亚州洛杉矶,专注于创新药物研发相关业务,在生物制药领域开展研发与商业化运营。
GOLD vs PBYI — 直观对比
营收规模更大
GOLD
是对方的2.0倍
$75.5M
营收增速更快
PBYI
高出122.3%
-94.6%
自由现金流更多
PBYI
多$61.0M
$-46.6M
两年增速更快
PBYI
近两年复合增速
-76.2%
损益表 — Q2 FY2026 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $148.1M | $75.5M |
| 净利润 | $11.6M | — |
| 毛利率 | 63.0% | 69.3% |
| 营业利润率 | 10.7% | 22.7% |
| 净利率 | 7.9% | — |
| 营收同比 | -94.6% | 27.7% |
| 净利润同比 | 77.4% | — |
| 每股收益(稀释后) | $0.46 | $0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
GOLD
PBYI
| Q4 25 | $148.1M | $75.5M | ||
| Q3 25 | $3.7B | $54.5M | ||
| Q2 25 | $2.5B | $52.4M | ||
| Q1 25 | $3.0B | $46.0M | ||
| Q4 24 | $2.7B | $59.1M | ||
| Q3 24 | $2.7B | $80.5M | ||
| Q2 24 | $2.5B | $47.1M | ||
| Q1 24 | $2.6B | $43.8M |
净利润
GOLD
PBYI
| Q4 25 | $11.6M | — | ||
| Q3 25 | $-939.0K | $8.8M | ||
| Q2 25 | $10.3M | $5.9M | ||
| Q1 25 | $-8.5M | $3.0M | ||
| Q4 24 | $6.6M | — | ||
| Q3 24 | $9.0M | $20.3M | ||
| Q2 24 | $30.9M | $-4.5M | ||
| Q1 24 | $5.0M | $-4.8M |
毛利率
GOLD
PBYI
| Q4 25 | 63.0% | 69.3% | ||
| Q3 25 | 2.0% | 77.7% | ||
| Q2 25 | 3.3% | 76.5% | ||
| Q1 25 | 1.4% | 77.1% | ||
| Q4 24 | 1.6% | 76.4% | ||
| Q3 24 | 1.6% | 63.9% | ||
| Q2 24 | 1.7% | 77.4% | ||
| Q1 24 | 1.3% | 75.5% |
营业利润率
GOLD
PBYI
| Q4 25 | 10.7% | 22.7% | ||
| Q3 25 | -0.0% | 17.6% | ||
| Q2 25 | 0.5% | 12.7% | ||
| Q1 25 | -0.3% | 8.7% | ||
| Q4 24 | 0.3% | 22.6% | ||
| Q3 24 | 0.4% | 27.4% | ||
| Q2 24 | 1.3% | -4.6% | ||
| Q1 24 | 0.2% | -5.3% |
净利率
GOLD
PBYI
| Q4 25 | 7.9% | — | ||
| Q3 25 | -0.0% | 16.2% | ||
| Q2 25 | 0.4% | 11.2% | ||
| Q1 25 | -0.3% | 6.5% | ||
| Q4 24 | 0.2% | — | ||
| Q3 24 | 0.3% | 25.2% | ||
| Q2 24 | 1.2% | -9.6% | ||
| Q1 24 | 0.2% | -11.0% |
每股收益(稀释后)
GOLD
PBYI
| Q4 25 | $0.46 | $0.26 | ||
| Q3 25 | $-0.04 | $0.17 | ||
| Q2 25 | $0.43 | $0.12 | ||
| Q1 25 | $-0.36 | $0.06 | ||
| Q4 24 | $0.27 | $0.40 | ||
| Q3 24 | $0.37 | $0.41 | ||
| Q2 24 | $1.29 | $-0.09 | ||
| Q1 24 | $0.21 | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | — | $97.5M |
| 总债务越低越好 | — | $22.7M |
| 股东权益账面价值 | $653.8M | $130.3M |
| 总资产 | $3.8B | $216.3M |
| 负债/权益比越低杠杆越低 | — | 0.17× |
8季度趋势,按日历期对齐
现金及短期投资
GOLD
PBYI
| Q4 25 | — | $97.5M | ||
| Q3 25 | — | $94.4M | ||
| Q2 25 | — | $96.0M | ||
| Q1 25 | — | $93.2M | ||
| Q4 24 | — | $101.0M | ||
| Q3 24 | — | $96.7M | ||
| Q2 24 | — | $96.8M | ||
| Q1 24 | — | $107.2M |
总债务
GOLD
PBYI
| Q4 25 | — | $22.7M | ||
| Q3 25 | — | $34.0M | ||
| Q2 25 | — | $45.3M | ||
| Q1 25 | — | $56.7M | ||
| Q4 24 | — | $68.0M | ||
| Q3 24 | — | $79.3M | ||
| Q2 24 | — | $90.7M | ||
| Q1 24 | — | $102.0M |
股东权益
GOLD
PBYI
| Q4 25 | $653.8M | $130.3M | ||
| Q3 25 | $644.0M | $115.3M | ||
| Q2 25 | $649.5M | $104.7M | ||
| Q1 25 | $643.6M | $97.1M | ||
| Q4 24 | $612.7M | $92.1M | ||
| Q3 24 | $611.1M | $71.1M | ||
| Q2 24 | $607.6M | $48.5M | ||
| Q1 24 | $583.2M | $51.0M |
总资产
GOLD
PBYI
| Q4 25 | $3.8B | $216.3M | ||
| Q3 25 | $2.6B | $202.9M | ||
| Q2 25 | $2.2B | $194.9M | ||
| Q1 25 | $2.2B | $196.2M | ||
| Q4 24 | $1.9B | $213.3M | ||
| Q3 24 | $2.0B | $220.7M | ||
| Q2 24 | $1.8B | $205.0M | ||
| Q1 24 | $1.7B | $214.1M |
负债/权益比
GOLD
PBYI
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | 0.30× | ||
| Q2 25 | — | 0.43× | ||
| Q1 25 | — | 0.58× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 1.12× | ||
| Q2 24 | — | 1.87× | ||
| Q1 24 | — | 2.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $-42.6M | $14.4M |
| 自由现金流经营现金流 - 资本支出 | $-46.6M | $14.4M |
| 自由现金流率自由现金流/营收 | -31.5% | 19.1% |
| 资本支出强度资本支出/营收 | 2.7% | 0.0% |
| 现金转化率经营现金流/净利润 | -3.66× | — |
| 过去12个月自由现金流最近4个季度 | $310.3M | $41.7M |
8季度趋势,按日历期对齐
经营现金流
GOLD
PBYI
| Q4 25 | $-42.6M | $14.4M | ||
| Q3 25 | $195.4M | $9.7M | ||
| Q2 25 | $67.0M | $14.1M | ||
| Q1 25 | $102.8M | $3.6M | ||
| Q4 24 | $110.1M | $15.6M | ||
| Q3 24 | $-127.5M | $11.0M | ||
| Q2 24 | $82.8M | $1.0M | ||
| Q1 24 | $79.8M | $11.2M |
自由现金流
GOLD
PBYI
| Q4 25 | $-46.6M | $14.4M | ||
| Q3 25 | $193.4M | $9.7M | ||
| Q2 25 | $63.1M | $14.1M | ||
| Q1 25 | $100.4M | $3.6M | ||
| Q4 24 | $106.4M | $15.6M | ||
| Q3 24 | $-128.1M | $11.0M | ||
| Q2 24 | $80.1M | $1.0M | ||
| Q1 24 | $79.1M | — |
自由现金流率
GOLD
PBYI
| Q4 25 | -31.5% | 19.1% | ||
| Q3 25 | 5.3% | 17.7% | ||
| Q2 25 | 2.5% | 26.8% | ||
| Q1 25 | 3.3% | 7.7% | ||
| Q4 24 | 3.9% | 26.4% | ||
| Q3 24 | -4.7% | 13.7% | ||
| Q2 24 | 3.2% | 2.1% | ||
| Q1 24 | 3.0% | — |
资本支出强度
GOLD
PBYI
| Q4 25 | 2.7% | 0.0% | ||
| Q3 25 | 0.1% | 0.0% | ||
| Q2 25 | 0.2% | 0.0% | ||
| Q1 25 | 0.1% | 0.1% | ||
| Q4 24 | 0.1% | 0.0% | ||
| Q3 24 | 0.0% | 0.0% | ||
| Q2 24 | 0.1% | 0.0% | ||
| Q1 24 | 0.0% | 0.0% |
现金转化率
GOLD
PBYI
| Q4 25 | -3.66× | — | ||
| Q3 25 | — | 1.10× | ||
| Q2 25 | 6.49× | 2.41× | ||
| Q1 25 | — | 1.21× | ||
| Q4 24 | 16.78× | — | ||
| Q3 24 | -14.20× | 0.54× | ||
| Q2 24 | 2.68× | — | ||
| Q1 24 | 15.91× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图